
Atara Biotherapeutics Investor Relations Material
Latest events

AGM 2024
Atara Biotherapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Atara Biotherapeutics Inc
Access all reports
Atara Biotherapeutics Inc. is a biotechnology company focused on developing therapies for cancer, autoimmune, and viral diseases. The company specializes in allogeneic T-cell immunotherapy, using off-the-shelf T-cells to target and treat diseases. Atara's lead programs are centered around developing treatments for conditions such as Epstein-Barr virus-associated cancers and multiple sclerosis. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Atara Biotherapeutics Inc


Q3 2024
Atara Biotherapeutics Inc


Q1 2024
Atara Biotherapeutics Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ATRA
Country
🇺🇸 United States